Skip to Content

Synergy CHC Corp SNYR

Morningstar Rating
$0.01 0.00 (0.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

SNYR is trading at a 37% discount.
Price
$0.01
Fair Value
$3.15
Uncertainty
Extreme
1-Star Price
$4.82
5-Star Price
$7.44
Economic Moat
Qtvcyhj
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if SNYR is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.01
Day Range
$0.010.01
52-Week Range
$0.010.03
Bid/Ask
$0.05 / $0.07
Market Cap
$898,890.74
Volume/Avg
21,300 / 21,300

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Synergy CHC Corp is a consumer health care company. It is in the business of marketing and distributing consumer branded products through various distribution channels primarily in the health and wellness industry. The company's products include FOCUSfactor, Flat Tummy Tea, Hand MD, and Neuragen amongst others. Synergy generates the majority of its revenue from the sale of Flat Tummy Tea, which is exclusively sold online at www.flattummyco.com. Flat Tummy Tea is a uniquely formulated two-step herbal detox tea that works to naturally help speed metabolism, boost energy and reduce bloating.
Sector
Healthcare
Industry
Medical Distribution
Stock Style Box
Total Number of Employees
36

Valuation

Metric
SNYR
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
SNYR

Financial Strength

Metric
SNYR
Quick Ratio
0.34
Current Ratio
0.55
Interest Coverage
−11.50
Quick Ratio
SNYR

Profitability

Metric
SNYR
Return on Assets (Normalized)
−21.57%
Return on Equity (Normalized)
−188.63%
Return on Invested Capital (Normalized)
−27.88%
Return on Assets
SNYR
See how this stock stacks up to its competitors with Morningstar Investor

Medical Distribution Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
MCK
McKesson CorpLqnlmrdbpXnvwlx$69.9 Bil
COR
Cencora IncGyztflzlLyzxsz$47.4 Bil
CAH
Cardinal Health IncFdrbywsvCjnqvl$25.1 Bil
SHTDY
Sinopharm Group Co Ltd ADRDbjfgn$8.3 Bil
SHPMY
Shanghai Pharmaceuticals Holding Co Ltd ADR repr Class HYwpfcz$8.2 Bil
SHPMF
Shanghai Pharmaceuticals Holding Co Ltd Class HFrztkh$8.1 Bil
SHTDF
Sinopharm Group Co LtdMqnlvdw$7.9 Bil
AMFPF
Amplifon SpA Az nom Post FrazionamentoVnlvx$7.7 Bil
MAHLY
Medipal Holdings Corp ADRZxzg$3.3 Bil
MEPDF
Medipal Holdings CorpSwvm$3.3 Bil

Sponsor Center